Staidson Beijing Biopharmaceuticals competitive analysis

Loading summary...

Explore Staidson Beijing Biopharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 11, 2021Nerve Growth Factor Composition And Powder Injection1
Jun 2, 2021Nerve Growth Factor Composition And Powder Injection1

Latest publications and patents of Staidson Beijing Biopharmaceuticals New

Explore the latest publications and patents granted to Staidson Beijing Biopharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Staidson Beijing Biopharmaceuticals

Aug 11, 2021Nerve Growth Factor Composition And Powder InjectionRevoked
Jun 2, 2021Nerve Growth Factor Composition And Powder InjectionRevoked

Latest PTAB cases involving Staidson Beijing Biopharmaceuticals

Discover the latest PTAB cases involving Staidson Beijing Biopharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Staidson Beijing Biopharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
STAIDSON BEIJING BIOPHARMACEUTICALS - 2 - -
DOMPE FARMACEUTICI2 - - -